about
Cell-permeable MR contrast agents with increased intracellular retentionThe magnetic, relaxometric, and optical properties of gadolinium-catalyzed single walled carbon nanotubesSelf-aggregated dinuclear lanthanide(III) complexes as potential bimodal probes for magnetic resonance and optical imaging.Dysprosium complexes and their micelles as potential bimodal agents for magnetic resonance and optical imaging.Micellar self-assemblies of gadolinium(III)/europium(III) amphiphilic complexes as model contrast agents for bimodal imaging.Gd(III)-labeled peptide nanofibers for reporting on biomaterial localization in vivoProgesterone-targeted magnetic resonance imaging probesA multimeric MR-optical contrast agent for multimodal imagingTheranostic Magnetic Nanostructures (MNS) for Cancer.Assembly of near infra-red emitting upconverting nanoparticles and multiple Gd(III)-chelates as a potential bimodal contrast agent for MRI and optical imaging.Magnetofluorescent micelles incorporating Dy(III)-DOTA as potential bimodal agents for optical and high field magnetic resonance imaging.Gd-hydroxypyridinone (HOPO)-based high-relaxivity magnetic resonance imaging (MRI) contrast agents.Bioresponsive, cell-penetrating, and multimeric MR contrast agents.Near infrared-fluorescent and magnetic resonance imaging molecular probe with high T1 relaxivity for in vivo multimodal imaging.Bifunctional Eu(3+)-doped Gd(2)O(3) nanoparticles as a luminescent and T(1) contrast agent for stem cell labeling.Cyclodextrin-based bimodal fluorescence/MRI contrast agents: an efficient approach to cellular imaging.Lanthanide(III) complexes of rhodamine-DO3A conjugates as agents for dual-modal imagingIn vivo imaging of molecular targets and their function in endocrinology.Multimodality imaging probes: design and challenges.Trajectory control of PbSe-gamma-Fe2O3 nanoplatforms under viscous flow and an external magnetic field.Synthesis and biological evaluation of water-soluble progesterone-conjugated probes for magnetic resonance imaging of hormone related cancersPyridine-based lanthanide complexes combining MRI and NIR luminescence activities.Analytical methods for characterizing magnetic resonance probes.Protein polymer MRI contrast agents: Longitudinal analysis of biomaterials in vivo.Longitudinal near-infrared imaging of myelination.Synthesis and characterization of new porphyrazine-Gd(III) conjugates as multimodal MR contrast agentsA modular system for the synthesis of multiplexed magnetic resonance probes.Synthesis and characterization of a porphyrazine-Gd(III) MRI contrast agent and in vivo imaging of a breast cancer xenograft model.A steroid-conjugated magnetic resonance probe enhances contrast in progesterone receptor expressing organs and tumors in vivo.Reporter protein-targeted probes for magnetic resonance imaging.Folate receptor-targeted fluorescent paramagnetic bimodal liposomes for tumor imaging.Synthesis, relaxivity, and in vitro fluorescence imaging studies of a novel d-f heterometallic trinuclear complex as a potential bimodal imaging probe for MRI and optical imaging.Multimeric Near IR-MR Contrast Agent for Multimodal In Vivo Imaging.Hybrid 2D nanomaterials as dual-mode contrast agents in cellular imagingDiscrete bimodal probes for thrombus imaging.Analysis of Lanthanide Complex Dendrimer Conjugates for Bimodal NIR and MRI Imaging.A dual-modal magnetic nanoparticle probe for preoperative and intraoperative mapping of sentinel lymph nodes by magnetic resonance and near infrared fluorescence imaging.Nanocrystal core high-density lipoproteins: a multimodality contrast agent platformMn₃[Co(CN)₆]₂@SiO₂ core-shell nanocubes: novel bimodal contrast agents for MRI and optical imaging.Magnetic nanoparticles in MR imaging and drug delivery.
P2860
Q28755262-0A461A09-DF29-4880-BC6E-6D12BF8C0D0EQ30622441-B43553DB-CAAD-40CE-AAC0-24B51AB1A9FAQ30654757-DFC63BF8-1B69-457C-950F-96E79D108F91Q30677097-4CB9A91A-F975-4125-A733-9D109D32BB62Q30729090-A4862D22-9B16-4502-8530-672B8058EB3FQ30831724-744FBA33-2584-4D0E-9A37-2EF26C0014A5Q30836342-B7B59AD4-02E1-48B3-9C5E-7B9FE546F401Q30843582-269D0B69-A4B2-4E6A-A69D-C7288F77BF10Q30937214-D43C1D50-FDFC-4F71-A99D-158055709A73Q30958749-EE2F1C1A-8D4D-4CA6-9D23-D2D6ABBE9EEEQ31044226-6E5EA592-8691-4F9E-B4EF-73231D2461FBQ33463644-3317A5DB-C2DA-40D2-87E9-C53010E4E21EQ33470566-C38E61B6-4B64-4EFC-A7FB-B86D0FF461B9Q33555204-3AB13E43-C48C-41D7-9DB9-BA1CE296E3F9Q33564661-C34F9F9C-5866-4BF7-9E29-1F23143B2716Q33617992-79DD882B-EE9D-4306-B1D6-A4F88ACE3EB5Q33623967-6D970C9A-F451-4EE9-9D32-D2DC189A58E6Q33637199-38FF87A2-57BC-427A-94F0-B629A6F82349Q33884695-B25827E7-D195-4D1F-9B08-CA714DCC5974Q33901763-7AD3EE90-D7C1-4923-99A3-5637ED2B63AEQ34040411-A6DDB54B-1E1F-4034-A0E7-AB3FA43897BAQ34115952-569B87B1-22D6-4924-8B20-8EA4371658EFQ34280357-65FED47B-2AA6-4741-92E9-347BC7C10F08Q34367708-367022FD-A191-4B05-B308-79215FD32A7DQ34603512-B4E53794-F66C-46E9-843C-89A4809DBAA2Q34785712-4A10B824-59CF-4C08-94C3-8C98D07D7E48Q34913014-A91A5BD0-EEB6-4A9E-9FAC-60DD31E0BD2DQ35082611-75ABEB7A-D463-4892-AB98-B2BD44594807Q35141461-8D35723E-AFDC-4853-8717-2AF4B3F19462Q35468836-1EA7FD09-28A5-4277-9B89-4A549D4B1E22Q35488256-BE5E8BFF-93A2-4FD2-8CEC-53B1FB73898FQ35786129-904A99CA-6550-4278-9BCB-175CBCFFFD04Q35883228-F4414F83-5035-4029-BE65-21FFCF0144CCQ36090969-C7241809-D415-4509-9D16-8A132B0AF69DQ36095999-E9D45AF6-69CA-4EBC-82D3-979343276694Q36443368-73961758-85A9-45B4-B9D7-435582E84F7FQ37003215-E9812A3C-270E-431D-90B8-9C0FFC9F0710Q37069877-69B82E9E-6FAA-4B68-AAB1-DBAF81B0AA31Q37165329-C8353073-95C5-49D1-AEBA-4C2EB4DAE5BAQ37192908-921917AB-E0D3-4912-8619-F65C98A3A357
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Multimodal MRI contrast agents.
@en
type
label
Multimodal MRI contrast agents.
@en
prefLabel
Multimodal MRI contrast agents.
@en
P1476
Multimodal MRI contrast agents.
@en
P2093
Luca Frullano
Thomas J Meade
P2888
P304
P356
10.1007/S00775-007-0265-3
P577
2007-07-21T00:00:00Z